FDA Approves Transplant Trials for Gene-Edited Pig Kidneys
The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics Corporation will start with six patients but could grow its trial to include up to 50 individuals, while eGenesis plans to begin with three patients.
FDA approves the first clinical trials for pig kidney transplants in humans, testing genetically modified pig organs.
Yet fewer than 25,000 kidney transplants were performed ... then three months before transplanting a third. Even if these trials prove successful, the cost of pig organ transplants and ...
The FDA has approved the first-ever clinical trials for pig kidney transplants in humans marking a breakthrough in tackling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback